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Estrogen receptorsA historical perspective on estradiol's enhancement of cognitive function is presented, and research, primarily in
animals, but also in humans, is reviewed. Data regarding the mechanisms underlying the enhancements are
discussed. Newer studies showing rapid effects of estradiol on consolidation of memory through membrane
interactions and activation of inter-cellular signaling pathways are reviewed as well as studies focused on tradi-
tional genomicmechanisms. Recent demonstrations of intra-neuronal estradiol synthesis and possible actions as
a neurosteroid to promote memory are discussed. This information is applied to the critical issue of the current
lack of effective hormonal (or other) treatments for cognitive decline associated with menopause and aging.
Finally, the critical period hypothesis for estradiol effects is discussed along with novel strategies for hormone/
drug development. Overall, the historical record documents that estradiol positively impacts some aspects of
cognitive function, but effective therapeutic interventions using this hormone have yet to be realized.
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Evidence, accumulated over the past 25 years, shows that estradiol
modulates cognitive function in animals and humans. Modulation
begins in utero when estrogens direct sexual differentiation of various
brain regions controlling reproduction and some cognitive functions.
Gonadal hormone inﬂuences on the nervous system, including both
estrogens and androgens, continue through adolescence and reach
their zenith at adulthood when gonadal hormone secretions reach the
highest levels. With aging, levels of circulating estrogens plummet and
appear to contribute to age-related declines in learning and memory
function. These hormone-dependent effects on cognition over the
lifespan have been attributed to classic, genomic mechanisms —
hormone binding to speciﬁc receptors, alterations in gene transcription
and the initiation of organ-speciﬁc effects in target areas in the brain
and peripheral organs. More recently, it has also been established that
gonadal hormones, including estradiol, can act at membrane receptors
to activate intra-cellular signaling mechanisms which alter cellular
function. Moreover, there is increasing documentation that gonadal
hormones are neurosteroids, that is, estrogens and androgens are syn-
thesized locally in brain areas and thereby rapidly alter cognition and
other neural functions. The physiological functions and implications
for this mode of estrogen action are unknown at this time but present
a novel area for investigation. Finally, in a more global way, estradiol
also acts indirectly to maintain cognitive functions because it exerts
neurotrophic effects within the brain. Thus, gonadal hormones, estradi-
ol in particular, have a rich repertoire of possible mechanisms for
inﬂuencing cognition.
This review provides a brief overview of studies establishing
estrogen's role in promoting cognition primarily in animal models but
also in humans, and it discusses some data regarding the mechanisms
underlying these inﬂuences. Newer studies demonstrating how estro-
gens rapidly alter learning and memory are discussed. The need for
exploiting this information is emphasized as it may provide an entirely
novel area for therapeutic interventions for memory loss. The failure of
current hormone replacement therapy in post-menopausal women is
used to highlight the importance of implementing basic research com-
bined with translational studies in order to develop new treatments
and strategies for memory loss.
Overall, gonadal hormones exert diverse and multi-dimensional
inﬂuences on some aspects of cognitionwhich are pervasive throughout
the lifespan and provide fundamental regulation over higher order
neural function, i.e., the intellectual/cognitive realms of life. Accumulat-
ing, but still controversial, evidence suggests that estradiol, synthesized
within the hippocampus and prefrontal cortex, may also contribute to
the normal process(es) of memory consolidation. Since the review
covers such widespread topics, each cannot be discussed in depth, but
the reader is directed to current reviews. The review concludes that
research on estrogens which act as potent hormones, neurosteroids
and neuromodulators should be expanded in order to take advantage
of already demonstrated cognitive enhancements, to extend positive
hormonal effects throughout the entire lifespan and to determine how
estrogens may be of value in mitigating neurodegenerative diseases.
More provocatively, since intra-neuronally derived estrogens may beinvolved in the normal process(es) of memory consolidation, it is
argued that further research may lead to a better understanding of the
fundamental processes of learning and memory. The path for achieving
these goals is to forge a strong and more informative translation from
animal to human studies and to integrate newer information on
estradiol's neurosteroid and neuromodulator effects with its traditional
genomic effects in order to develop new target drugs. While enormous
progress has been made in the last twenty-ﬁve years, the breadth and
depth of new developments concerning neural mechanisms for estradi-
ol action suggest that researchers will continue to be engaged in this
area of neuroendocrine research for the near and far future.
Deﬁning cognition
Cognitive function, put in its most basic context, is the ability to
learn, retain, and recall information. In humans, it also represents a
complex, multidimensional set of intellectual functions like judgment
and evaluation. Thus, in a broader context, cognition includes all mental
abilities and processes related to knowledge including, but not limited
to, attention,memory, reasoning, comprehension and language produc-
tion. Since this review focuses primarily on animals, but also includes
human research, cognition is used in its more basic context. In addition,
since effects of the gonadal steroid, estradiol, are considered, learning
and memory (information recall) is the cognitive function which com-
prises much of the discussion because it has been studied the most in
relation to estrogen's effects. Nonetheless, because effects of estradiol
have been demonstrated in a number of cognitive domains in humans
and in a number of different learning and memory paradigms in
animals, cognition or cognitive function will be used for general discus-
sion. It should be noted that such usage does not indicate that estradiol
inﬂuences all aspects of cognitive functioning.Moreover, some effects of
estradiol may be mediated by non-cognitive processes (see Dohanich,
2002; Luine and Dohanich, 2008; Luine, in press and the section Adult
cognition for further discussion of these issues). When speciﬁc studies
and experiments are described, the exact cognitive process investigated
and effects found will be given.
Areas and mechanisms for gonadal hormone action
In 1998, Hormones and Behavior devoted an entire issue to the topic
of Estrogen Effects on Cognition Across The Lifespan (Williams, 1998)
which gave credence to the newly developing concept that hormones,
especially estrogens, couldmodulate cognitive function. Historically, es-
tradiol had been recognized to act within the brain to regulate sexual
behavior and ovulation in the late sixties (Everett, 1965; Gorski,
1971), and this research area contributed greatly in the founding of
the journal. Currently, the role of gonadal hormones in brain functioning
has expanded, and many higher order brain functions such as mood,
psychiatric disorders and some social behaviors, as well as cognition
are now known to be impacted (Watson et al., 2010; Gillies and
McArthue, 2010). Thus, hormonal inﬂuences on cognition no longer
seem unusual, and, indeed, gonadal hormone effects on neural func-
tions are pervasive.
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tems in the cerebral cortex, basal forebrain, hippocampus and striatum
that regulate higher order neural function. The most investigated areas
formemory in general, and for hormonal effects onmemory speciﬁcally,
are the medial prefrontal cortex and hippocampus. Cognitive effects of
estradiol, similar to effects on reproduction, aremediated through bind-
ing to classical nuclear receptors which are found in two distinct forms,
estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ), in
these brain areas (Fig. 1). Both receptors are ligand dependent tran-
scription factors and through interactions at speciﬁc sites on DNA
(EREs, estrogen response elements), initiate a cascade of intra-cellular
reactions that alter protein synthesis and culminate in the unique phys-
iological responses of each estrogen target tissue. These genomic actions
generally result in long lasting and sustained effects on neural function
and most likely underlie estrogen effects during development when
sex-dependent functions and sex differences in neural functions are
programmed, although recent studies indicate that epigenetic mecha-
nisms may also contribute to sexual differentiation (McCarthy and
Nugent, 2013). At adulthood, functional changes which occur during
the menstrual and estrous cycles, pregnancy, menopause and aging
are also dependent on genomic mechanisms. While changes in cogni-
tion appear to depend on genomic mechanisms, current research
suggests that other mechanisms such as binding to membrane recep-
torsmay also be important. This line ofwork beganwith the demonstra-
tion that estrogen receptors were present outside of the cell nucleus in
membranes of cell bodies, spines and presynaptic terminals in a number
of brain regions including the medial PFC and the hippocampus
(Srivastava et al., 2013b). Binding of estrogens to membrane receptors
initiates rapidlymediated hormonal effects (sec tomin) through activa-
tion of signaling pathways (Fig. 2). Thus, estrogen can alter memory,
and other functions, through mechanisms that are rapid or slow in
onset.Developmental effects of gonadal hormones on cognition
Animal studies
Inﬂuences of gonadal hormones on cognition begin during in
utero development when the testes of males actively secrete testos-
terone, which directly masculinizes the male external genitalia. In
the central nervous system, testosterone is aromatized to estradiol,NNeuro
ERE Gene Expression
Protein synthesis
ESTRADIOL
DNA
Cell Membrane
Neurotransmitter       Spines      Neurotrophins
Associated Proteins
ENHANCED COGNITIVE FUNCTION
ERα ERβ
Fig. 1. Schematic of genomic mechanism for enhancing memory by estradiol. Circulating
estradiol enters the cell nucleus where it can bind to two types of receptors, ERα or ERβ.
The complexes act as nuclear transcription factors by binding to an ERE (estrogen re-
sponse element) and stimulating gene transcription which leads to increases in cellular
proteins that, by increasing neural transmission and function, enhance cognitive function.and it is this locally produced estradiol which programs the expres-
sion of male-like behaviors including, most importantly, sexual
behavior. Estradiol also underlies the expression of some non-
sexual behaviors like aggression, activity and motor abilities and
some aspects of learning and memory (Watson et al., 2010; Gillies
and McArthue, 2010). These organizational events by estradiol
leave long lasting imprints which are manifested in sex differences
at adulthood and which in some (but not all) cases can be addition-
ally modulated by circulating estrogens and androgens. Sex behav-
iors are strikingly different between the sexes: rodent males
exhibit mounting and little lordosis while rodent females exhibit
lordosis and little mounting. Sex differences in non-sexual behav-
iors, including cognition can be less dimorphic/different, but male
rodents outperform females on tasks requiring spatial memory, the
radial arm maze (Williams et al., 1990; Luine and Rodriguez, 1994)
Morris water maze and object placement (Beck and Luine, 2002;
Bisagno et al., 2003). Fig. 3 illustrates this sex difference: on the
radial arm, maze female mice make approximately twice as many
errors as males in completing the task, and in object placement,
female rats signiﬁcantly discriminate only at a one hour inter-trial
delay while males discriminate with 1–4 h inter-trial delays.
Sex differences are also prominent in the strategies by which
cognitive tasks are accomplished in rodents. For example, in learning
to obtain rewards on the T-maze, two strategies can be utilized. One,
a place or spatial strategy, involves learning to go to a speciﬁc place
(arm), while a response strategy, which involves always turning
the same direction, can also be used. Korol et al. (2004) reported
that female rats were more likely to use a place strategy (but could
alter strategy based on estrus cycle state) while Packard and
McGaugh (1996) reported that 90% of male rats use a response
strategy. In solving the spatial memory task, radial armmaze, female
andmale rats also often apply different strategies which are reﬂected
in males having a faster rate and accuracy in learning the task, but
over time both sexes reach the same level of performance
(Williams and Meck, 1991; Tropp and Markus, 2001). Females
appear to construct a detailed cognitive map of all cues around the
maze which makes acquisition of the task slower but allows
for sustained, accurate performance even when cues are removed.
Males, on the other hand, map only a few cues and apply a “vectoring
approach,” use of the geometric properties of the shape of the
environment in relation to only a few cues. Hence males rapidly
map and acquire the task, but male performance plummets
when the environment is even minimally altered. Similar strategy
differences between the sexes and effects of hormones have
also been noted in the water maze (Korol et al., 2004; Daniel and
Lee, 2004).
An important question, which has not beenwidely investigated in
relation to these sex differences in cognition, is whether the differ-
ences are due to gonadal hormones acting during development
(organizing/programming effect) to establish long lasting neuroana-
tomical, chemical and/or functional sex differences. Alternatively,
sex differences in cognitive function may arise from differences in
circulating hormones in the sexes that act on neurons to inﬂuence
their function. In addition, the difference may depend on both
organizational and activational effects of hormones, and genes on
the Y chromosomemay also contribute. Little research has addressed
these issues but Williams and colleagues investigated the inﬂuence
of neonatal castration and estradiol treatment to females on ra-
dial maze performance and found that the treatments generally
mimicked the demonstrated sex differences of adult rats (Williams
et al., 1990; Williams and Meck, 1991). Neonatal exposure to testos-
terone also modiﬁes sex differences in radial arm and Morris water
maze performance and hippocampal morphology (Roof, 1993;
Isgor and Sengelaub, 1998). Thus, results suggest a strong organizing
effect of estradiol, derived from testosterone, on adult sex differ-
ences in the acquisition and performance of spatial memory tasks.
Fig. 2. Schematic of rapid membrane receptor mediatedmechanisms for enhancing memory by estradiol. Circulating estradiol can bind to various receptors in the cell membrane. At this
time, the exact receptors and details of the binding have not been described, but evidence for activation of the pathways shown have been obtained (see text for details and references).
Binding to the receptors results in activation of protein kinases which phosphorylate other proteins. These proteins then cause increases in synthesis of speciﬁc proteins through either
phosphorylation of the transcription factor cAMP-response element-binding protein (CREB) located on DNA in the cell nucleus or through mRNAs located in the cytoplasm in dendrites
or other areas. These actions result in structural changes at existing synapses as well as synaptogenesis that enhance memory formation, consolidation, storage and retrieval. Abbrevia-
tions: ERK, extracellular signal regulated kinase; PKA, cAMP-dependent protein kinase; P13K/Akt, phosphatidylinositol3-kinase/Akt pathway; m pathway; mTOR, targets of rapamycin.
Schematic adapted from Frick (2012) and Giese and Mizuno (2013).
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Some gender differences in cognition are also apparent. A similar
pattern as in animals exists where most men outperform most
women in tasks requiring spatial contexts (Hampson, 1990). On
the other hand, most women are superior to men in aspects of verbal
abilities including spelling, grammar, and rate of speech acquisition
(Hampson, 2002). The same relationship, females superior to men,
exists in tests of perceptual speed and accuracy, and women also
exhibit better short-term memory (Hampson, 2002). Such tasks
cannot be assessed in rodents, and non-human primates have not
been investigated. Like rodents, it is unknown whether the differ-
ences are due to organizational or activational hormone effects.
Gender differences in spatial abilities are present in children (Kerns0
1
2
3
4
5 **
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   Males                  Females
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A B
Fig. 3. Sex differences in spatial memory tasks. A. Radial armmaze – Bars show the total errors
Data fromanunpublished study byKneavel, Christakos and Luine. B. Object placement task-Bars
and female rats in the recognition trial (T2) at inter-trial delays of 1,2, and 4 h. ANOVA showed a
ject. **P b 0.01, **P b 0.01, *P b 0.05 (paired t-test) within each group. Data adapted from Bisagand Berenbaum, 1991) and become larger at puberty (Voyer et al.,
1995) suggesting both kinds of hormonal inﬂuences. Women with
Congenital Adrenal Hyperplasia (CAH), a condition where testoster-
one is produced in large amounts by the adrenal glands beginning in
utero, provide an opportunity to assess organizational effects of
testosterone and estradiol (derived from the testosterone) on cogni-
tive function (activational effects of hormones cannot usually be
assessed because medical treatments effectively lower androgens).
Some, but not all, studies suggest that CAH women develop a more
male-typical cognitive pattern, especially with regard to spatial
memory, and this observation thus provides some evidence for
perinatal organizing effects on cognition in humans (Malouf et al.,
2006; Mueller et al., 2008; see Berenbaum and Beltz, 2011 for a
review).1 h Delay     2 h Delay        4 h Delay
**
* * *
 Object Placement in Rats
    1-4 h Inter-trial Delays
made in completion of the task by adult male and female mice. **P b 0.01, Student's t-test.
represent themean time±SEMexploring the object at the old and new locations formale
signiﬁcant difference in time spent at the locations and a signiﬁcant interaction, sex × ob-
no et al. (2003).
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usually small in magnitude, with the largest differences usually consti-
tuting a little more than one standard deviation unit, and some studies
have failed to demonstrate such differences. Thus, while an “average”
female may score higher than an “average” male on a particular test,
there is considerable overlap in performance, and some men will
score higher than some women.
An important aspect of the programming of sex differences during
development is that these differences may contribute to the develop-
ment and patterns of adult cognitive loss seen in some neurodegenera-
tive and psychiatric diseases. Females have more Alzheimer's disease
and less Parkinson's disease than males and develop Parkinson's later
than males. Schizophrenia develops earlier in males, and males present
withmore negative symptoms and possiblymore cognitive deﬁcits than
females (Gillies and McArthue, 2010). Sex differences in these diseases
as well as responses to drug treatments have initiated the gender
medicine movement. Gender medicine posits that we need to do
away with the assumption that men and women are similarly affected
by diseases and treatments. Further emphasizing the importance of
sex in biological systems, the National Institutes of Health (N.I.H.) has
recently unveiled policies to ensure that preclinical research funded
by the US NIH includes both females and males (Clayton and Collins,
2014). Clearly, most current research does not include both sexes, and
we have only scratched the surface on the extent to which sex contrib-
utes to biological functions, especially cognition.
In conclusion, further studies of sex differences in cognition and the
role of possible organizing effects of gonadal hormones on cognition are
necessary to determine to determine the extent to which this period of
development makes contributions to normal cognitive function and
effects of neurodegenerative disease. It should also benoted that adoles-
cence is a period where hormones may contribute to long lasting, sexu-
ally dimorphic patterns of behavioral performance (Schulz et al., 2009),
and this period needs further investigation in relation to the setting
down of sex-dependent, cognitive attributes. Answers to these ques-
tions are important because they could frame the type and nature of
successful hormonal treatments given in adulthood.
Adult cognition
Introduction and caveats
Research conducted in many laboratories has documented cogni-
tive changes in female rodent models in relation to gonadal hormone
status, and these changes include effects related to ovariectomy,
estrous cyclicity, pregnancy, multiparity, estrapause and aging
(Dohanich, 2002; Luine, 2006, 2008; Luine and Frankfurt, 2012a,b).
Studies presented in the 1998 issue and somewhat later utilized pri-
marily spatial memory tasks such as radial arm maze, Morris water
maze and T-maze to show that estradiol administration improved
performance of ovariectomized rats (Luine and Rodriguez, 1994;
Luine et al., 1998; Daniel et al., 1997; Dohanich et al., 1994;
Dohanich, 2002). Differences in performance of tasks were also
found across the estrous cycle (Frye et al., 2007; Walf et al., 2006;
Frick and Berger-Sweeney, 2001; Frye, 1995; Warren and Juraska,
1997). It should be emphasized that reported changes are small
and not all studies reported positive effects, but at this time, the pre-
ponderance of studies report enhancements of learning andmemory
by estradiol. It is also important to note whether studies examined
learning vs memory as differential effects of estrogens have been
reported on these aspects of cognition (Dohanich, 2002). Many
issues have contributed to reported failures of estradiol in enhancing
cognitive function. It is important to review these issues because
“failures” contribute to the notion held by some scientists that
estrogens do not exert modulation of cognition. In addition, knowl-
edge of potential pitfalls is helpful in designing future, successful
experiments.Experimental design issues in assessing hormone effects
Type of “estrogen”
As indicated previously, a preponderance of studies show that
gonadal hormones enhance cognitive function, but many studies report
no or marginal effects. First, some confusion has arisen over the use of
the general term estrogen(s), as compared to the speciﬁc hormone,
17β-estradiol (Blaustein, 2008). Several types of estrogens are synthe-
sized and secreted by the ovaries, commonly referred to as E1 (estrone),
E2 (17α and 17β-estradiol) and E3 (estriol). 17β-Estradiol is the most
prevalent and most potent female gonadal hormone followed by
estrone and estriol, at least as indicated by binding afﬁnity to ERα and
potency in inducing uterine growth (MacLusky, 1997; Folmar et al.,
2002). Most animal studies utilize 17β-estradiol or 17β-estradiol–ben-
zoate (EB). EB provides longer and more sustained increases in serum
17β-estradiol because the benzoate moiety protects estradiol from
rapid degradation. Use of 17β-estradiol or EB leads to different effective
doses and time courses for effects (Scharfmanet al., 2007). Some studies
have also used the synthetic estrogen, diethylstilbestrol (DES), which is
more potent than any endogenous estrogen (MacLusky, 1997; Luine
et al., 2003). Long term, sustained levels of estradiol can be achieved
by use of Silastic capsules packed with pure hormone or diluted with
cholesterol. Estradiol is slowly released, and constant levels can be
maintained for one to six months (Brown et al., 1990; Rodgers et al.,
2010). A rapidly metabolized, water-soluble form of estradiol which is
encapsulated in 2-hydroxypropyl-β-cyclodextrin (estradiol–cyclodex-
trin) does not enter cells and can be used can be used for assessing
effects of estradiol mediated through binding to membrane receptors
(Frick, 2012).
Many studies in women have not utilized the above described
estrogens but instead used the most commonly available and pre-
scribed Hormone-Replacement Therapy (HRT) formulation, Premarin,
which consists of Conjugated Equine Estrogens (CEE; trade name
Premarins) (Hersh et al., 2004). These conjugated estrogens are primar-
ily a mixture of sodium estrone sulfate and sodium equilin sulfate with
other components in lesser amounts including sodium sulfate conju-
gates of 17α- and 17β-dihydroequilin, 17α-estradiol (isomeric form
of estradiol which binds poorly to estrogen receptors) and trace
amounts of 17β-estradiol. The presence of equilin compounds reﬂects
that Premarins were originally obtained from the urine of pregnant
horses. Currently, these estrogens are obtained from other natural
sources. After absorption andmetabolism of CEEs, the resulting primary
circulating hormones are estrone and, after estrone's conversion, 17β-
estradiol, as well as equilin, but only the levels of estrone and equilin
have been reported (Bhavnani, 2003; Sitruk-Ware, 2002). These three
metabolites are hypothesized to be primarily responsible for the estro-
genic effects of CEE (Sitruk-Ware, 2002), although there are other estro-
gens and related metabolites that could also exert effects (Kuhl, 2005).
Most of these estrogenic compounds have not been extensively investi-
gated in animals or humans, but effects of individual components as
compared to CEE appear to differ as estrone impaired (Engler-
Chiurazzi et al., 2012), dehydroestrone enhanced and equiline had no
effect on memory tasks in middle aged rats (Talboom et al., 2010)
while low dose Premarin impaired learning and memory retention
but medium and high doses enhanced it in middle aged rats (Engler-
Chiurazzi et al., 2011; see Acosta et al., 2013 for further discussion). In
women with a uterus, Premarin (as well as estradiol) must be given
with a progestin, such as Medroxyprogesterone acetate, because uter-
ine cancer can develop with chronic estrogen treatment. As with
Premarin, Medroxyprogesterone acetate is not an endogenous proges-
tin. In general, fewer positive effects on cognition in women have
been noted after CEE treatments as compared to treatment with estra-
diol itself (see the section Human studies and the critical period
hypothesis). Unfortunately, some studies using CEE (referred to as
estrogen replacement studies, ERT), which failed to see cognitive
enhancements, were erroneously assumed to have used estradiol.
Sex, Stress and Aging Effects on
Radial Arm Maze
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Fig. 4. Radial arm maze performance in rats across sex, age and after stress. Bars are the
average± SEM of the choice where subjects made the ﬁrst mistake (Larger numbers indi-
cate better performance). Young males and females (2–3 months) served as controls or
received daily restraint for 21 days. Old rats were 22–24 months old. Chronic stress
impairs young male performance but enhances female performance. Both aged males
and females are impaired as compared to young controls, and aged females show the
worst performance of all the groups. Data are combined form a number of studies and
are for illustrative purposes only as no statistical tests were performed. See the original
studies for details and statistical analyses.
Data from Luine and Rodriguez (1994), Luine et al. (1990), and Bowman et al. (2001).
Reprinted by permission from Luine (2006).
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The estradiol dose given is critical because many drug/hormone
effects on cognition do not follow a traditional sigmoidal shaped
dose–response curve but instead show an inverted U-shape with both
lower and higher doses being ineffective or even inhibitory (Inagaki
et al., 2010). Thus, experiments which include only one dose, or even
two doses, of hormonemay not show positive effects or even inhibitory
effects. The duration, days vs weeks, or type of treatment, injection vs
sustained release capsules, are important as different effects have
been obtained, even on the same cognitive tests (Luine et al., 1998;
Fernandez and Frick, 2004; Galea et al., 2001, 2002). The delay period
between ovariectomy and the initiation of estrogen treatment in animal
models (McLaughlin et al., 2008) or after menopause in humans
also critically impacts on the effectiveness of estrogens (see the
section Human studies and the critical period hypothesis). At present,
it appears that the longer the interval between cessation of circulating
gonadal hormones and initiation of treatment, the smaller the response,
and this observation holds for both ovariectomyparadigms and natural-
ly occurring estrapause in rats and may extend to women.
Life history
For animal studies, the life history of the subjects maybe important
and can interact with or interfere with treatments. Environmental
enrichment mitigates or obliterates some estrogenic effects on cogni-
tion (Daniel et al., 1999), especially in aged rodents (Gresack and
Frick, 2004). Diet can contribute to effects in rodents because
phytoestrogens (plant-derived estrogens with weak potencies) are
present in rat chow. Long-term maintenance of ovariectomized rats
on chow containing high phytoestrogen levels or treatment with
phytoestrogens is associated with better performance of somememory
tasks as compared to ovariectomized rats receiving chowwith minimal
phytoestrogens (Luine et al., 2006; Pan et al., 2010). Thus, ceiling effects
could be present when environmentally enriched or phytoestrogen ex-
posed rats receive chronic estrogen treatments. Dietary phytoestrogens
may also be critical in aging studies since aged females have low circu-
lating estradiol. Thus, feeding chowhigh in phytoestrogensmay provide
maintenance or enhancing effects of estrogens.Multi-parity, having had
multiple pregnancy, birth and lactation bouts, mitigates age-related
declines in spatial memory, and thus such subjects may also respond
differently when given estradiol treatments as compared to age-
matched virgins (Macbeth et al., 2008; Gatewood et al., 2005). Thus,
many factors interact with hormonal effects and appear to minimize
or obscure the effects and need to be taken into accountwhen executing
experiments.
Issues of life experiences have not been well addressed in women,
but some studies show that women having had multiple pregnancies
may show enhancements in certain aspects of memory (Macbeth and
Luine, 2010). Moreover, some clinical data suggest that estrogen treat-
ment may be most effective in women with less education (Mathews
et al., 1996, 1999) or who show normal to below average verbal mem-
ory performance (Tierney et al., 2013) which effects may be similar to
the ceiling effect of environmental enrichment in rats.
Inter-actions between the HPG and HPA axes
Further complicating studies on estrogen effects are possible inter-
actions of the hypothalamic-pituitary-gonadal axis (HPG) with the
hypothalamic-pituitary-adrenal (HPA) axis. The HPA is activated with
stress and resultant release of corticosterone (in rats) or cortisol (in
humans) can interfere or alter responses to gonadal hormones. In rats,
depending on the intensity or duration of stress and the sex and age
of the subject, memory can be impaired or enhanced (Luine et al.,
2007). Interactions between the HPA and HPG axis are critical because
many learning and memory tasks in animals rely on negative (shock
or swimming until ﬁnding a hidden platform) or positive (food or
water after privation) reinforcements which introduce stresses to the
subjects. In this regard, recognitionmemory tasks,which engender littlestress, show robust memory enhancements by estrogen in reports from
a number of different laboratories (Luine, in press) while stress encoun-
tered during performance of some tasks which have stressful compo-
nents such as the water maze, radial arm maze and avoidance
paradigms may interfere with or override results (Beck and Luine,
1999; Englemann et al., 2006).
Indirect effects on psychological performance parameters
A ﬁnal consideration is whether estradiol acts on mnemonic pro-
cesses to enhance memory or whether the enhancements reﬂect indi-
rect effects on psychological performance parameters. Hormones can
inﬂuence performance parameters like affect (arousal, anxiety, mood,
motivation), regulatory mechanisms (thirst, hunger, bodyweight, com-
position, temperature), sensory-perception (vision, audition, olfaction,
gustation, touch, attention, proprioception, nociception) and motor
ability (activity, balance, skill) (Luine and Dohanich, 2008). These per-
formance parameters are present in both animal and human tests and
could thereby enhance or impair performance. Human experiments
usually include other instruments to assess these parameters and the
extent to which they contribute to main effects, and thus, these compli-
cations are usually ruled out but could still remain as possiblemediators
of estrogenic effects. Accounting for performance variables in animal
experiments is more difﬁcult, but many investigators have tested
them (Luine and Dohanich, 2008; Luine et al., 2003; Inagaki et al.,
2010) or have utilized testing paradigmswhich preclude effects on per-
formance parameters (Luine, in press; see the section Post-training trial
injections and memory enhancement).
Does estradiol inﬂuence cognition?
Does the above list of potential caveats indicate that estrogenic inﬂu-
ences on cognition may occur only in circumscribed situations and be
only marginal in real time? Data on this question is presented in the
next section, but the reader is referred to Fig. 4 where performance on
the spatial learning and memory task, eight arm radial arm maze, is
shown in adult male and female rats, adults receiving chronic stress
and aged (25 months old) rats. Sex differences are expected, and they
are obvious; males, regardless of age, perform better than females. The
608 V.N. Luine / Hormones and Behavior 66 (2014) 602–618response to stress is different in the sexes; males are impaired after
stress while females perform better. Moreover, it is overwhelmingly
clear that old female rats are severely compromised in their cognitive
abilities as compared to all groups. Thus, both gonadal and adrenal
hormones appear to impact cognition, and old female rats, with very
low circulating levels of estrogens, are severely compromised. Whether
lack of estrogen is a main contributor to age-related learning and
memory losses in females is unknown, but this ﬁgure certainly begs
the question. It is also known that spatial reference memory on the
Morris water maze declines remarkably faster with aging in female
rats, 12 months old, than male rats, 18 months old (Markowska,
1999) or in female mice, 17 months old, than male mice, 25 months
old (Frick et al., 2000).Estradiol enhancements of cognition — chronic effects
Animal studies
The results of extensive research, using a variety of learning and
memory tasks, show that estradiol enhances cognition (Dohanich,
2002; Frick, 2009; Luine, 2008). The balance of studies show estrogen
dependent enhancements in performance during the acquisition
phase (Daniel et al., 1997; Luine et al., 1998; Luine and Rodriguez,
1994), but when subjects have acquired (learned) how to complete/
solve the tasks, estradiol may no longer enhance performance (Fader
et al., 1998, 1999; Luine et al., 1998). Effects of estradiol on response
learning, mediated by the striatum, have not been well studied, but it
may impair this type of learning in females (Zurkovsky et al., 2011;
Davis et al., 2005).
When memory is assessed in spatial and non-spatial tasks (using
and remembering within trial information), consistent enhancements
by estradiol are seen (reviewed in Luine, 2008). An example of
estradiol's ability to enhancememory is shown in Fig. 5 where two rec-
ognition memory tasks were evaluated, one is object recognition and
the other is object place recognition. In both tasks, rats explore two
identical objects in an open ﬁeld in the training or sampling trial, and
then after an inter-trial delay of 4 h, a new object replaces one of the ob-
jects (object recognition) or a one object is moved to a new location
(object placement). If rats spend more time exploring the new object
or the object in the new location, it is considered that they remember
the old object/location. We gave estradiol benzoate (EB) or vehicle to
ovariectomized rats via SC injection (50 μg/kg) for two days and
assessed object recognition or object placement memory 48 h after
the last estradiol injection (Jacome et al., 2010). As shown in Fig. 5A, Chronic EB Treatment
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Fig. 5. Effects of chronic estradiol on recognition memory in rats. A. Sample Trial (T1)— Explora
No signiﬁcant differences. B. Recognition trial (T2)— Trial was given 4 h post-T1 and entries are
for vehicle- and EB-treated subjects. Dotted line at 0.5 indicates spending the same amount of tim
of old vs new).
Figure reprinted with permission from Neurobiol. Learn. Mem. (Jacome et al., 2010).treatments did not alter exploration of objects in the sample trial. The
lack of differences in exploring the objects suggests that estradiol did
not alter the psychological performance parameters of overall activity,
anxiety for object exploration or novelty seeking behavior. In contrast,
during the recognition trials (Fig. 5B), estradiol treated rats had signiﬁ-
cantly higher exploration ratios than vehicle treated rats, approximately
0.70 vs. 0.50 (exploration ratio is time exploring new/time exploring old
+ new so a higher ratio indicates bettermemory). Thus, estradiol treat-
ment appeared to enhance memory. Nonetheless, it might still be ar-
gued that changes in performance parameters may have contributed.
We therefore tested the same estradiol treatment regimen for activity
and anxiety effects on the open ﬁeld and for anxiety effects on the ele-
vated plus maze. No differences between vehicle and estradiol treated
rats were noted suggesting that estradiol, at least at the dose and dura-
tion given, enhanced memory (Jacome et al., 2010). Localized infusion
of estradiol directly into the hippocampus is sufﬁcient to enhance
both recognition memory (Boulware et al., 2013) and spatial memory
in the water maze (Packard, 1998) which also argues against effects
on non-mnemonic parameters.
Chronic effects of estrogens appear to occurmainly through genomic
mediation, and the receptor(s) mediating the changes in recognition
memory were assessed using the ERα speciﬁc agonist PPT and the
ERβ speciﬁc agonists DPN and C19. Given in the same regimen as estra-
diol, only the ERβ agonists enhanced object recognition and object
placement (Jacome et al., 2010). Similar results have been reported by
others (Liu et al., 2008; Walf et al., 2008); however, some other studies
indicate that both receptors may mediate changes in memory (Frye
et al., 2007; Hammond et al., 2009; Boulware et al., 2013). Thus, it re-
mains unclear at this time whether estrogen binding to one or both of
the estrogen receptors mediate chronic changes in memory function.
Consistent with estradiol's enhancing effects in ovariectomized
females, ovariectomy is associated with a loss in the ability to signiﬁ-
cantly discriminate in recognition memory tasks (Wallace et al.,
2006). Interestingly, object recognition is affected before object place-
ment, 1 vs 4 weeks following ovariectomy which may reﬂect differ-
ences in amount or kind of estrogen receptors in the PFC vs the
hippocampus or the ability of the hippocampus to synthesize estrogens
in order to maintain memory function (see the section Synthesis of
estradiol within brain areas).Human studies
Effects of estrogens in humans generally reﬂect effects seen in
animals but are less consistent. Assessed over the menstrual cycle,Chronic EB Treatment
Recognition Trial (T2)
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tion times ± SEM for object and place tests are shown in vehicle- and EB-treated subjects.
the ratios (new/old+ new) of time spent exploring each object or objects in each location
e exploring new and old objects or locations. ***Pb 0.001 (paired t-testwithin each group
609V.N. Luine / Hormones and Behavior 66 (2014) 602–618women do better on cognitive tests favoring females (verbal ﬂuency,
ﬁne motor skills, perceptual speed) when estrogens are high but per-
form better on cognitive skills favoring males, spatial ability, when
estrogens are low (Hampson, 1990; Hampson and Morley, 2013;
reviewed in Sherwin, 2012). A recent study in young, cycling women
(Hampson andMorley, 2013) showed that when their salivary estradiol
levelswere high, 7.3 pmol/L, they had fewerworkingmemory errors on
a spatial working memory task than when their levels were low,
2.2 pmol/L (Fig. 6A). Moreover, salivary estradiol signiﬁcantly correlat-
ed with the number of working memory errors (Fig. 6B). On the other
hand, another recent study reported no changes in immediate or work-
ingmemory, delayed recall, verbal learning or verbal ﬂuency across the
menstrual cycle (Mihalj et al., 2014). Still, postmenopausal women
(with presumably low estradiol levels) performed signiﬁcantly worse
than pre-and perimenopausal women on delayed verbal memory
tasks and signiﬁcantly worse than perimenopausal women on
phenomic verbal ﬂuency tasks (Weber et al., 2013). In terms of estrogen
treatment paradigms, young women with a surgical menopause who
were treated with estradiol maintained performance on tests of verbal
memory whereas scores decreased signiﬁcantly in placebo treated
women (Sherwin, 1988). Most estrogen treatment studies in females
have been conducted after menopause and are discussed in the section
Human studies and the critical period hypothesis.Estradiol enhancements of cognition — acute effects
Background
During the 1990s, evidence accumulated that receptor(s) for estro-
gens were also present outside of the cell nucleus in membranes of
cell bodies and in axons, spines, presynaptic terminals, and near post-
synaptic neurotransmitter receptors (Blaustein, 1992; Milner et al.,
2001; Towart et al., 2003). Brain regions mediating reproductive func-
tion like the hypothalamus as well as regions mediating cognition,
including themedial PFC and the hippocampus, were shown to contain
these non-nuclear receptors. Thus, our lab and others began investigat-
ing whether estrogens might more rapidly activate sex behavior or
learning and memory than in previous studies where injections of
17β-estradiol benzoate or Silastic capsules of 17β-estradiol were given
for several days or weeks.A B
Fig. 6. Relationship of salivary estradiol to workingmemory errors in young women. A. The mea
fromTrial 1 to Trial 3 (T1—T3) and in the delay condition (Delay) forwomen tested at low estrad
(Males, n = 31). Bars represent SEM. A. Scatterplot showing the association between salivary e
number of working memory errors on the spatial working memory task. With all females in th
Figures reproduced with permission from Hampson and Morley (2013).In initial studies of recognition memory, 17α- or 17β-estradiol
(15 μg/kg)was given to ovariectomized subjects 30min before explora-
tion of objects in T1, and the T2 recognition/retention trialwas given 4 h
later (Luine et al., 2003). Ovariectomized rats did not signiﬁcantly
discriminate between the objects, but both 17α- and 17β-estradiol
treated subjects signiﬁcantly discriminated between the old and the
new objects and the old and new locations (no differences in explora-
tion were seen in T1). 17α-Estradiol binds to membrane receptors so
it was not surprising that it also enhanced memory (MacLusky, 1997).
DES also enhanced OR and OP in the same pre-T1 paradigm (Luine
et al., 2003). Thus, a variety of estrogens rapidly enhanced recognition
memory, 4.5 h after injection. Moreover, the effective doses after acute
treatments were much lower than in studies where estrogens were
given chronically, 50 μg/kg/day (Jacome et al., 2010) vs 15 μg/kg dose
(Luine et al., 2003). Supporting these novel behavioral ﬁndings, inhibi-
tory avoidance, a task relying on conditioned learning, was also
enhanced by a similar dose (10 μg) of 17β-estradiol within 4 h
(Rhodes and Frye, 2004).Post-training trial injections and memory enhancement
In subsequent studies, we and others adopted a post-training proto-
col for assessing memory as advanced by McGaugh (1989). There are
two important advantages for this protocol: psychological performance
parameters and learning are largely eliminated. Thus, memory can be
investigated. In this protocol, treatments are given after subjects acquire
information such as searching for the submerged platform in water
maze tasks or having explored objects in recognition tasks (T1 Trial).
Following the acquisition or training trial, new information requires
consolidation, and drugs or hormones could inﬂuence memory storage
processes during this immediate period following training. Studies by
the McGaugh laboratory showed that rats receiving injections of drugs
like amphetamine or noradrenergic agonists had better retention from
the training trial (1989). Moreover, the post-training injections were
time dependent, only treatments given within 1–2 h following the
training/sampling trials enhanced memory, and those given later in
the inter-trial delay did not. The important attribute of post-training
protocols is that enhancements after immediate, but not delayed,
post-trial injections show that the enhancing effects on memory do
not derive from non-mnemonic effects during learning since then number of workingmemory errors (WME) observed on a spatial workingmemory task
iol (Group I, n=18),women tested at high estradiol (Group II, n=21), andmale controls
stradiol concentrations after log transformation to normalize the distribution and the total
e sample included (n = 39), a correlation of r =− .40 was found.
Fig. 7. Immediate, but not delayed, post-sample trial estradiol injections enhance object
placement memory. A. Injections of 20 ug/kg of 17β-estradiol immediately after T1
enhancedobject placementmemory 4 h later. Left panel: exploration times aroundobjects
during T1. Middle panel: time spent exploring objects at old and new locations during T2.
Right panel: exploration ratios during T2. Dashed lines at 0.5 indicate chance level perfor-
mance. Entries aremeans± SEM. **P b 0.01. B. Injections of 17β-estradiol 45 min after T1
did not enhance memory. Panels as in A.
Figure reprinted by permission from Inagaki et al. (2010).
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training injections in recognition memory tasks, reported that estradiol
enhances consolidation of memory when given immediately following
T1 but not when given between 45 min and 2 h after T1, depending
on the dose of estradiol and the inter-trial delay between T1 and T2
(Packard, 1998; Luine et al., 2003; Lewis et al., 2008; Fernandez et al.,
2008; Inagaki et al., 2010, 2012; Jacome et al., 2010; Luine, in press).
Fig. 7 shows that S.C. 17-β-estradiol (20 μg/kg) enhances object
placement when given immediately following the sample trial, but not
when given 45 min after the sample trial. Thus, estradiol enhances
consolidation of memory. The dose–response curves for post-T1 estro-
gen effects are inverted U curves which is consistent with other mem-
brane mediated effects (Inagaki et al., 2010; Watson et al., 2010).
Other studies show that immediate, post-sample trial enhancements
of object recognition in ovariectomizedmice are present 48 h following
estradiol (see Frick, 2012). In addition, 17β-estradiol–cyclodextrin
(does not pass through cell membranes) applied directly to the dorsal
hippocampus immediately following T1 enhances object memory
(Fernandez et al., 2008; Lewis et al., 2008) or place memory
(Boulware et al., 2013) suggesting that estrogenic activation within
the hippocampus is sufﬁcient to enhance memory for objects or places
in a post-sample trial paradigm. Packard (1998) had earlier reported
that post-training injections of estradiol, either IP or intra-hippocampal,
enhanced Morris water maze performance 24 h later.
Thus, recent studies show that estrogens can rapidly enhance con-
solidation of memory in recognition memory tasks as well as in spatial
memory dependent water mazes and inhibitory avoidance. These
effects open whole new areas for investigation and are consistent with
information that the hippocampus may synthesize estradiol de novo
(see the section Synthesis of estradiol within brain areas). However, it
is unknown whether such rapid effects of estrogens occur in women.
Nonetheless, this mechanism of estradiol action may provide the basis
for developing drugs that act as estrogens but not through classic, geno-
mic mechanisms. This idea is further explored in the section Novel
strategies for estradiol replacement/treatments.Neural mechanisms for chronic and acute effects of estrogens
Background
Ample evidence exists that estrogens cause morphologic and
neurochemical changes in many areas of the brain when given acute-
ly or chronically to animals or humans. Chronic treatments alter the
major neuronal systems of the brain including, but not limited to,
cholinergic, monoaminergic, GABAergic and glutaminergic neurons
in both animals and humans (Gibbs, 2010; McEwen and Alves,
1999). Cholinergic neural systems have been the most extensively
investigated. Cholinergic cell bodies originate in the vertical and hor-
izontal diagonal bands and n. basalis areas within the basal forebrain
and project to the hippocampus and frontal cortex. On the behavioral
side, estrogen treatments which enhance learning and memory in
rodents are associated with increases in cholinergic neurochemicals,
synthetic enzymes, receptors, or RNA for the chemicals (Luine, 1985;
Dohanich et al., 1994; Daniel and Dohanich, 2001; Gibbs, 2010).
Cholinergic antagonists also block or interfere with performance of
learning and memory tasks and with estrogen's enhancements in
their performance in rodents and humans (Fader et al., 1998, 1999;
Dohanich, 2002; Dumas et al., 2008, 2012). In humans, for example,
post-menopausal women received three months of oral 17β-
estradiol or placebo and then underwent a visual verbal N-backtest
of working memory while undergoing functional MRI. Immediately
prior to the session, subjects were administered the antimuscarinic
drug scopolamine, the antinicotinic drug mecamylamine or placebo.
Results showed that estradiol modulated antimuscarinic and
antinicotinic-induced brain activity and provided further evidence
that estradiol affects cholinergic system regulation of cognition-
related brain activation (Dumas et al., 2012). Thus, as illustrated for
the cholinergic system, chronic estradiol treatments up regulate
neuronal systems which in turn then enhance cognition.
Dendritic spine density
Increasing evidence shows that the general mechanism(s) underlying
learning and memory involve dendritic remodeling. In the hippocampus,
the acquisition of newmemories in a conditioning paradigm is associated
with increases in dendritic spine density in the CA1 region of both male
(Jedlicka et al., 2008; Leuner et al., 2003) and female rats (Beltran-
Campos et al., 2011). In addition, existing spines undergo structural alter-
ations that result in long term potentiation (Jedlicka et al., 2008;
Morgado-Bernal, 2011). The functional implications of these alterations
in spine density are best understood in the hippocampus because
increases in dendritic spine density and/or spine sizes are associated
with long term potentiation (Muller et al., 2000, LTP [81,86]. Overall, it
appears that memories require alterations in dendritic spines that then
alter LTP (Matsuzaki et al., 2011). In relation to estrogen effects, Vedder
et al. (2013) recently showed that treatment for two days enhanced
novel object recognition memory with the same time course as increases
in CA1 LTP magnitude, and both effects required an increase in NMDA
receptors. With regard to hippocampal spines and memory, it is notable
that chronic treatmentwith estradiolwas shown to increasehippocampal
dendritic spine density 25 years ago (see McEwen and Alves, 1999 for
review) and that it is now abundantly clear that dendritic spines are
extremely responsive to both acute and chronic changes in circulating
estrogen. For ex., ﬂuctuations of approximately 30% in dendritic spine
density on neurons in the ventromedial hypothalamus nucleus (impor-
tant for female sexual behavior) (Frankfurt et al., 1990) and pyramidal
cells in the CA1 region of the hippocampus occur during the 4–5 day
estrous cycle (Woolley and McEwen, 1992). Similar results have been
obtained in the monkey for CA1 (Hajszan and Leranth, 2010; Parducz
et al., 2006) and the PFC (Tang et al., 2004; Leranth et al., 2008) where
estradiol has been shown to increase both dendritic spine and spine
synapse density. Moreover, we have demonstrated that ovariectomized
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an object placement task and have an approximately 10% higher spine
density in basal CA1 dendritic spines than ovariectomized rats (Luine
and Frankfurt, 2013). Li et al. (2004) reported that 1 μg of estradiol for
5 days, a dose which enhances object placement, also increases mush-
room spine density in CA1 of ovariectomized mice. Velázquez-Zamora
et al. (2012) showed that estradiol increased spine density in layer III of
the PFC at the same dose which enhanced allocentric working memory
in the Y-maze. Consistent with estradiol administration to ovariectomy
rats enhancing memory, ovariectomy is associated with a signiﬁcant
decline in recognition memory (object recognition and placement) and
17–55% lower spine density in the PFC and CA1 as compared to intact
rats (Wallace et al., 2006; Beltran-Campos et al., 2011). Aged rats showing
impaired recognition memory in comparison with young rats have
approximately 16% lower spine density in PFC and CA1 (Wallace et al.,
2008; Luine et al., 2011). Thus, over the lifespan of female rats, both
memory function and spine density in CA1 region of the hippocampus
and the medial PFC ﬂuctuate, but whether the dendritic changes are
causal to the memory changes has not been demonstrated (see Luine
and Frankfurt, 2012b for further discussion).
Rapid effects of estradiol on morphology and neurochemistry have
also been demonstrated. Within 30–40 min after injection, estradiolFig. 8. Photomicrograph of estradiol effects on secondary basal dendrites in CA1. A. Spine
density is shown at 30 min following injection of vehicle. Arrows indicate spines on the
secondary basal dendrites at ×100. B. Spine density is shown at 30 min following injec-
tions of 20 ug/kg of 17β-estradiol. Arrows indicate spines on the secondary basal dendrites
at ×100. Reprinted with permission from Inagaki et al. (2012).increases post-synaptic synapse density by 62% (MacLusky et al.,
2005) and spine density by 29% in basal dendritic spines in CA1
(Inagaki et al., 2012; Phan et al., 2012). Fig. 8 is a photomicrograph
showing CA1 spine density in ovariectomized rats 30 min after receiv-
ing either vehicle or 20 μg estradiol. Increases in PFC spine density are
also noted within the same time frame in both apical, 16%, and basal,
27%, trees (Inagaki et al., 2012) and in arcuate nucleus (Christensen
et al., 2011). Changes in all areas are maintained for 4 h after estradiol
administration. Khan et al. (2013) recently reported rapid increases in
spines in the somatosensory cortex, an area believed to contribute to
working memory, as well as the PFC. As indicated above, spine changes
are at a dose and time when memory consolidation is known to occur
(Luine and Frankfurt, 2012a). As with chronic estradiol treatments,
whether relationships between the variables are causal requires further
investigation.
Cell signaling
Our understanding of how the brain acquires, consolidates and
retrieves information has advanced rapidly in the last twenty years.
Several lines of evidence support the critical role of signaling cascades
and protein kinases in the process (Giese and Mizuno, 2013 and see
Fig. 2). There is evidence that estradiol activates many of these path-
ways. In the hippocampus, the initial event in activating intracellular
signaling which is responsible for memory consolidation appears to be
the activation of glutamate receptors (mGluR), primarily MGluR1.
These events are responsible for triggering LTP induction and memory
formation (see Sweat, 2010 for review). It has recently been shown
that estradiol rapidly activates in vivo mGluR signaling in the PFC and
hippocampus (Meitzen and Mermelstein, 2011; Khan et al., 2013;
Boulware et al., 2013) and several kinases (see below). ERs have been
identiﬁed on membranes of dendrites and spines, in presynaptic termi-
nals and near post-synaptic receptors, and estradiol binding to these ERs
initiates rapid activation of intracellular signaling cascades and immedi-
ate early genes which are critical for memory consolidation (Srivastava
et al., 2013b). These effects are well described by in vitro and in vivo
experiments, but the receptor(s) responsible are still unclear. Both
ERα and ERβ have been localized to membranes in the hippocampus
and PFC (Milner et al., 2001, 2005; Bean et al., 2014; Khan et al.,
2013), and estradiol also binds to a G-Protein coupled receptor
(GPR30) which is expressed at high levels in the hippocampus
(Brailoiu et al., 2007). However, the role of this receptor remains unclear
because rapid enhancements in recognition memory occur at levels of
estradiolwhich are below its binding afﬁnity for GPR30, and the binding
afﬁnity of various estrogens for GPR30 are not consistent with their
effects on memory (Inagaki et al., 2012). However, GPR30may collabo-
rate with an ER to promote cell signaling (Langer et al., 2010).
In relation to the previous discussion of increased spines as a mech-
anism for enhancing memory consolidation, estrogen rapidly activates
several signaling cascades involved in the formation of spines and in
regulating spine/synapse size (McEwen et al., 2012; Srivastava, 2012;
Kramar et al., 2013). Acting through membrane receptors, estradiol
increases the phosphorylation of RAS/Raf,MEK, ERK and P13Kpathways
which in turn increase phosphorylation of the transcription factor cAMP
response element-binding protein (CREB) (Fig. 2). CREB decreases tran-
scription of Coﬁlin, which allows for increased polymerization of actin
polymers for assembly of spines and for increased transcription of
actin, and RhoA, which is necessary for ﬁlopodial extension and spine
formation (Kramar et al., 2013; Luine and Frankfurt, 2012a,b).
Phosphorylation of P13K also leads to increases in AkT and 4E-BP1
which enhances PSD-95 formation, an integral framework for synapse
formation (McEwen et al., 2012). Enhanced ERK/MAPK signaling by
estradiol may also enhance memory consolidation by activation of epi-
genetic processes such as histone acetylation and DNAmethylation that
enhance the expression of genes and synthesis of proteins (Fortress and
Frick, 2014). Speciﬁcally, a recent in vivo study showed that estrogen
612 V.N. Luine / Hormones and Behavior 66 (2014) 602–618treatment increased dendritic spine number in the PFC as well as
spinophilin expression (Khan et al., 2013). Follow up in vitro studies
showed that estradiol enhanced AMPA GluR1 receptor expression and
excitatory glutamatergic synapse formation through increased ERK
and Akt activation. Similar effects have been reported in the hippocam-
pus using an in vivo approach; localized infusion of estradiol into CA1
enhanced recognition memory in an ERK dependent manner, and an
mGluR1 antagonist blocked memory enhancements by estradiol, PPT
(ERα agonist), or DPN (ERβ agonist) showing that ER/mGluR signaling
can mediate estradiol enhanced memory consolidation in the hippo-
campus (Boulware et al., 2013). Other mechanisms for enhancedmem-
ory consolidation in the hippocampus include estradiol-dependent
increases of brain derived neurotrophic factor (BDNF) through activa-
tion of an estrogen response element on the BDNF gene, or through
interactions with BDNF's membrane receptor (TrKB), or through other
growth factor receptors in membranes (Luine and Frankfurt, 2013;
Srivastava et al., 2013a). Growth factor receptor activation includes
phosphorylation of P13K and AkT with activation of mTOR which can
directly increase protein synthesis or interact with ERK to alter tran-
scription (Luine and Frankfurt, 2013; Srivastava et al., 2013a). Elegant
behavioral and molecular studies by the Frick lab (reviewed in Frick,
2012) have put these observations together to show that systemic or
intra-hippocampal estradiol enhances object and placememory consol-
idation in rats and that this effect is associated with rapid activations of
NMDA receptors and multiple cell signaling cascades.
Thus, ample molecular and morphological evidence shows that
estradiol causes both acute and chronic changes in a number of brain
areas important for cognition. Important questions remaining are
whether these effects are similar across the lifespan, from development
through adulthood and aging, or whether they change. Most of the
above studies were conducted in adult rodents. Differences in how
estrogen interacts with and alters neural function over the lifespan
can have an enormous impact for well-being as discussed in the next
sections.
Synthesis of estradiol within brain areas
Evidence has accumulated that signiﬁcant concentrations of estradi-
ol are produced locally in discrete regions of the brain by the enzyme
aromatase from androgen precursors such as testosterone and/or
directly from cholesterol and that these levels are higher than in the
circulation. Recently, Kato et al. (2013) reported that the concentration
of 17β-estradiol was 4 nM in the hippocampus of a female rat during
proestrus while circulating concentrations were only 0.1 nM. In addi-
tion, estradiol remained present in the hippocampus following ovariec-
tomy. The in situ production of estradiol indicates that it may act as a
neurosteroid as well as a gonadal steroid, and some evidence shows
that it may be a neuromodulator (Balthazart and Ball, 2006; Saldanha
et al., 2011). This work opens up a completely new area of investigation
concerning the role of locally synthesized estrogens in neural function.
Brain-synthesized estradiol was ﬁrst measured in birds and has been
recognized as a mediator of neural functions in regions of a number of
avian species (Boon et al., 2010; Saldanha et al., 2011). In addition,
in vitro studies report that hippocampal estradiol synthesis is important
for themaintenance of hippocampal spines, synapses and synaptic pro-
teins in cultures from rats (Hojo et al., 2004), and a recent in vivo study
showed that hippocampal spine density correlated with hippocampal
estradiol concentrations over the estrus cycle (Kato et al., 2013). Aroma-
tase has been detected in human brain via immunocytochemistry, gene
expression and in vivo PET scan studies (Biegon et al., 2010), but
whether neurally derived estradiol plays a role in development or in
neuromodulation is unexplored.
An important question for the present review is whether neurally
derived estrogens contribute to learning and memory. Support for this
idea comes from earlier studies showing that stimulation of hippocam-
pal slices with NMDA signiﬁcantly increases estradiol synthesis (Hojoet al., 2004) and that forebrain estradiol levels in songbirds are rapidly
regulated by voltage-gated calcium channels (Remage-Healey et al.,
2011). Direct support for hippocampal derived estradiol contributing
to memory came in a recent zebra ﬁnch study which showed that
local inhibition of hippocampal aromatization impaired spatial memory
performance in an ecologically valid food-ﬁnding task (Bailey et al.,
2013). Neural estradiol may also contribute to sex differences in cogni-
tive responses to stress. Several laboratories have shown that chronic
stress impairs spatial memory in male, but not female, rats (Luine
et al., 2007), an effect which was attributed to neuroprotective effects
of estrogens which are present in greater amounts in females than
males. Surprisingly, ovariectomized rats showed preserved spatial
memory on either the radial arm or Y maze following chronic stress
(Bowman et al., 2002; McLaughlin et al., 2005). The resilience post-
ovariectomy was, at the time of these experiments, attributed to possi-
ble enduring, organizational effects of estradiol on neural function.
A recent study has provided evidence for the possibility that neural
synthesis of estradiol may mediate the resilience of females to stress
and has extended the observation to the PFC (Wei et al., 2014). Male,
but not female, rats were impaired by chronic stress on a temporal
order recognition memory (TORM) task mediated by the prefrontal
cortex through glutamate receptors. When aromatase was blocked
and the females were stressed, TORM was impaired suggesting that
estradiol synthesized in the PFC conferred stress resilience on the
females. Thus, work in the stress ﬁeld provides some evidence that de
novo brain estradiol may contribute to normal memory formation.
This provocative idea was previously advanced by Frick (2012) who
speculated that estradiol, which is synthesized and released in response
to speciﬁc learning events in the hippocampus, may facilitate normal
learning and memory processes. Since estradiol has now been reported
to be some forty times higher in the female rat hippocampus than in the
circulation (Kato et al., 2013), estradiol does appear to be a neurosteroid
in search of a function(s). This concept is further discussed in the
section Novel strategies for estradiol replacement/treatments.
Cognitive loss during normal aging
Background
With advancing age, most aspects of cognitive function suffer some
degree of deterioration, ranging from modest declines in healthy
animals and humans to devastating losses in people with neurodegen-
erative diseases associated with aging like Alzheimer and Parkinson
disease (Frick, 2009). Ascribing a speciﬁc role for estrogens or other pa-
rameters to age-related cognitive loss is difﬁcult because all factors are
confounded by the aging process itself. Nonetheless, it is notable that
in post-menopausal women, gonadal hormone levels plummet to near
undetectable levels, and in rats, after a period of persistent diestrus,
levels also decline to near undetectable. Thus, estradiol, which tends
to promote cognitive function, is extremely low at advanced ages in
females.
Animal Studies
Most aging studies have used male rats or mice, but the few studies
done in females also show age-related performance declines. Approxi-
mately 21–24 month old female rats show impairments in relation to
2–4 month old young females on most spatial memory tasks including
Y and T mazes (Aggleton et al., 1989), radial arm maze (Luine et al.,
1990; see also Fig. 4), Morris water maze (Markowska, 1999; Veng
et al., 2003), water radial arm maze (Bimonte et al., 2003), Barnes
maze (Barrett et al., 2009) and object placement (Luine et al., 2011).
Performance on the non-hippocampal dependent task, object recogni-
tion, also show declines with aging (Wallace et al., 2008). As indicated
earlier, female rodents show age related declines in spatial memory
tasks sooner than males (Markowska, 1999; Frick et al., 2000).
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that densities in aged female rats are 16% lower, as compared to
young rats, in apical dendrites of the PFC and CA1 but not different in
basal dendrites or in either dendritic tree of CA3 (Reviewed in Luine
and Frankfurt, 2012b). This decline with aging is smaller than the
decline in density following ovariectomy (Wallace et al., 2006). Small
synapses, as compared to large synapses, appear to be lost with aging
(Bloss et al., 2013). Overall, studies indicate that aging in female rats is
accompanied by losses in memory abilities, neural spines, reorganiza-
tion of synapses and lower estradiol levels. Whether there is a causal
relationship among the variables still requires further analyses and
investigation.
Human studies and the critical period hypothesis
During the 1980's and 1990's estradiol administration was shown
in several observational studies to promote memory during aging
and to possibly delay the onset and/or prevent Alzheimer's disease.
However, several larger and longer trials of HRT in women suffering
fromAlzheimer's disease found no cognitive beneﬁts, and this area of
work is no longer being actively pursued (reviewed in Luine, 2008).
With regard to normal aging and menopause, the eagerly anticipat-
ed, large scale, double-blind placebo controlled Women's Health
Initiative Study (WHI) conducted by the National Institutes of Health
found that hormone therapy with CEE (not estradiol) (Espeland
et al., 2004) or CEE plus MPA (Schumaker et al., 2003) given to
women aged 65 years and older and at least 15 years past normal
menopause, did not improve cognitive functioning and slightly
increased the risk of dementia (reviewed in Luine, 2008; Frick,A
C
Fig. 9. Estradiol treatment at middle age enhancesmemory in old age— evidence for the critical
estradiol treatment are comparable to ongoing estradiol treatment in aging ovariectomized ra
cholesterol control treatment (Cont Ch), continuous estradiol treatment (Cont E), or 40 days o
were tested every other month on a working memory task in an eight-arm radial maze dur
Mean number of total retroactive errors (±SEM) averaged across delay trials one (A), three (
group. *p b .05 vs. Cont Ch.
Adapted from Rodgers et al. (2010).2009). Thus, promotion of cognitive function by estradiol during
aging was also not supported. However, some previous observation-
al studies of menopausal women had shown that estradiol treatment
was associated with better verbal memory, working memory, and
visuospatial function, and with a lower risk of dementia, but these
results were found particularly among women who had initiated
treatment during, or soon after, the menopause (studies reviewed
in Frick, 2009). In addition, randomized clinical trials with 17β-
estradiol near the onset of menopause also showed beneﬁcial effects
of treatment on verbal and working memory (Joffe et al., 2006;
Phillips and Sherwin, 1992; Viscoli et al., 2005; Wolf et al., 1999).
Since women in the WHI trial were at least ﬁfteen years past meno-
pause when treatments were initiated, several investigators posited
that a critical period or window of opportunity may exist for positive
estrogen effects (Resnick and Henderson, 2002; Sherwin, 2012;
Singh et al., 2013; Maki, 2013). Thus, in order for estrogens to exert
positive effects on neural functioning, hormonal replacements
must be given close to the initiation of menopause. In addition,
some evidence indicated that even a short period of treatment,
given around menopause, might confer long term beneﬁts.
Some evidence for the critical period hypothesis in rodents was
already extant (Gibbs, 2000), and several groups have provided
new cognitive and neural evidence supporting the hypothesis (see
Daniel, 2013 for review). In short, if rats receive estrogen replace-
ments immediately after ovariectomy at middle age, even for only
a short period, they show superior learning and memory in old age
as compared to subjects ovariectomized at the same time but receiv-
ing no estrogen and show similar learning and memory abilities as
ovariectomized rats that receive continuous estrogen replacementB
D
period hypothesis. Results show that the enhancing effects onmemory of previousmidlife
ts. Middle-aged rats were ovariectomized and received implants resulting in continuous
f prior exposure to estradiol treatment that was terminated before testing (Prior E). Rats
ing which 1 min and 2.5 h delays were imposed between the 4th and 5th arm choices.
B), ﬁve (C), and seven (D) months after termination of estradiol treatment in the Prior E
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This enduring enhancement of spatial memory in middle-aged rats
by estradiol given for a short period after ovariectomy is illustrated
in Fig. 9. The mechanism(s) responsible for this apparent change in
responsivity to estradiol during the menopausal period is currently
unknown. A simple answer is that continuous, unopposed estradiol
(no progesterone) has different effects than naturally cycling effects,
but no evidence for or against this idea has emerged. Another mech-
anism for this time limited estrogen effect is changes in ERα expres-
sion (Daniel, 2013; Schreihofer and Ma, 2013; Witty et al., 2012).
Aged females show general decreases in this receptor with a speciﬁc
50% reduction in CA1 synapses which contain ERα immunoreactivity
(Adams et al., 2002). Moreover, estrogen increases ERα levels in
young but not aged rats (Adams et al., 2002), and, interestingly,
long-term ovarian hormone deprivation in middle-aged rats attenu-
ated the ability of subsequent estradiol treatment to increase levels
of ERα (Bohacek and Daniel, 2009). Like the behavioral ﬁndings,
only ten days of treatment initiated at the time of ovariectomy was
sufﬁcient to signiﬁcantly increase levels of ERα in the hippocampus,
but treatment initiated 5 months later was not. Yet, it is still unclear
why lowered ERα levels would lead to unresponsivity to estrogens
and/or negative effects (WHI trial). ERβ appears to act, in concert
with estradiol, as a negative regulator of ERα-mediated transcription
which may contribute to unresponsivity (Bean et al., 2014). Gene
expression in the hippocampus after estradiol treatment to young
as compared to middle-aged mice shows a different pattern of
change which may also contribute to mechanisms underlying the
critical period (Aenlle and Foster, 2010). Taking these observations
together Foster (2012) indicates that an age-related shift in ERα/
ERβ expression, combined with declining gonadal estradiol, may
impact estrogen's effects on transcription, cell signaling, neuropro-
tection, and neuronal growth leading to different effects than those
which occur prior to aging. Also related to the concept of aberrant
receptor function is the hypothesis that increased levels of ER
polymorphisms with aging could contribute to negative effects of
estradiol.
In summary, in rats, at least, there appears to be a time deﬁned win-
dowwhere estradiol acts to mitigate age-related cognitive declines and
changes in the neural underpinnings of the effects, but exactly how this
regulation occurs and how this knowledge might be therapeutically
translated (other than by appropriate estradiol treatments) is unclear
at this time.
Investigation of the critical period hypothesis is more difﬁcult in
women than in rats, but the limited results thus far provide both posi-
tive and negative data (Sherwin, 2012; Maki et al., 2011; Maki, 2013;
Grodstein, 2013). One older study evaluated women who had under-
gone bilateral oophorectomy prior to the onset of natural menopause
and had either used or never used estrogen replacement therapy (ET)
until age 50 (Rocca et al., 2007). The never use group had an increased
risk of cognitive impairment or dementia 30 years later as compared
with referent womenwhile users had no increased risk of cognitive im-
pairment or dementia which suggests that ET initiated immediately fol-
lowing a surgical menopause for several years has an enduring effect
30 years later. In another study, young (ages 50–62) and older (ages
70–81) postmenopausal women, who received estradiol or placebo for
three months, were administered a cholinergic challenge and tested
for verbal memory and attention (Dumas et al., 2008). Estradiol pre-
treatment signiﬁcantly attenuated the drug-induced impairments only
in the younger group which supports the concept of a critical period.
Bagger et al. (2005) also found that treatment with ET for 2 to 3 years
around menopause decreased risk of cognitive impairments 5–
15 years later by 64% as compared with those who received placebo.
Thus, these ﬁndings support the idea that 2–3 years of ET, initiated
closely in time to themenopausemay confer enduring cognitive protec-
tion. In contrast, results of other studies have not supported the critical
period hypothesis, and it is notable that CEE was utilized in most.Espeland et al. (2013), from theWHIMSY Study Group, gave additional
cognitive testing to selectedwomen in theWHI trial whowere closer to
menopause, aged 50–55, than other WHI participants when they
received CEEHRT. Thewomen receivedHRT for 7 years andwere tested
approximately 7.2 years after cessation of HRT, at approximately
67 years of age. For the primary outcome, cognitive function and the
secondary outcomes of verbal memory, attention, executive function,
verbal ﬂuency and working memory, there was no beneﬁt or any
increased risk. Hogervorst and Bandelow (2010) performed a meta-
analysis of 36 randomized treatment trials (various estrogen formula-
tions) and found that neither age of the women nor duration of time
elapsed when treatment was initiated since menopause signiﬁcantly
affected the cognitive outcome. Outcomes in the Kronos Early Estrogen
Prevention Study (KEEPS) which randomized postmenopausal women
from 42 to 59 years to low dose oral or transdermal estradiol (as com-
pared to CEE in theWHI trials) combined with progesterone or placebo
for up to 4 years is awaited (Wharton et al., 2013). It is notable that
results for coronary heart disease are consistent with the critical period
hypothesis as theWHIprovided initial indication of decreased heart dis-
ease risk in younger women, and other studies show decreased total
myocardial infarction risk and signiﬁcant reductions in atherosclerosis
progression with CEE treatment (Grodstein, 2013). Thus, whether
there is a critical period in women for estradiol's enduringmaintenance
of cognitive function awaits veriﬁcation by ongoing and future studies.
The future of research on estrogen treatments for women suffering
from memory loss and other symptoms due to premature menopause
(oophorectomy), menopause or aging should not necessarily rest on
the outcome(s) of experiments testing the critical period hypothesis. If
outcomes are positive, then estradiol replacement should be actively
given around menopause, but this outcome does not preclude the use
of newer and more effective HRTs. It is important to note that Premarin
was approved by the FDA for use in postmenopausal women in 1942
(Stefanick, 2005) and that nonew estrogenic treatments formenopause
have been implemented since that time. New doses of Premarin and
transdermal patches containing estradiol have been brought to market
but no novel compounds. If ongoing studies do not support the critical
period hypothesis, then research to understand why estrogens no
longer have positive impacts on neural function after the menopause
would be imperative, and the necessity of newer treatment strategies
and/or drugs would become paramount. Thus, research must continue
and translational strategies should be expanded in order to maximize
positive effects of estrogens on neural function.
Novel strategies for estradiol replacement/treatments
Research over the last twenty-ﬁve years has established that estradi-
ol inﬂuences cognitive function, but a surprising development has been
the expansion of possible mechanisms for estrogen's actions. New
receptors have been identiﬁed which can mediate genomic (ERβ) and
non-genomic changes (membrane receptors). In addition, estradiol
has also been identiﬁed to be a neurosteroid and most likely a
neuromodulator. Thus, understanding which mechanism(s) contribute
to cognition has become more challenging. Another complication for
research is that it appears that effects of estrogens may change over
the lifespan. This is especially critical for aging where it appears that
estradiol's positive effects are lessened as compared to its effects in
adulthood, and, in some cases, estrogens may even cause detrimental
effects. Thus, more basic research is critical, especially in aged models,
in order to understand how to maintain cognitive function during this
transition.
In relation to HRT therapies, it was noted above that Premarin has
been in use for HRT for approximately 75 years and that no new treat-
ment options are currently available to women. In the 1990's drug
development focused on synthesis of selective estrogen receptormodu-
lator compounds (SERMs)whichwould act as agonists in bone for treat-
ment of osteoporosis and also mitigate hot ﬂashes but not bind in the
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focus at that time. First and second generation SERMS, Tamoxifen and
Raloxifene, respectively, were relatively successful as agonists in bone
and antagonists in mammary tissue (MacLusky, 1997). Thus, they
were useful for treating osteoporosis and as an adjuvant therapy for es-
trogen receptor positive breast cancers, but theirmixed agonist/antago-
nist properties limited their use. Thus, it was a researchmilestonewhen
ERβ was discovered (Kuiper et al., 1997), and more receptor speciﬁc
SERMs were synthesized (Minutolo et al., 2011). Since ERβ is present
in the brain but in only minimum levels in the uterus and breasts, ERβ
speciﬁc SERMSheld great promise asHRTs because of expectedminimal
side effects. Several, DPN, C19 and WAY-200070, enhanced memory in
animal models (see the section Human studies for details). Unfortu-
nately, estrogen therapy is currently not approved by the US FDA for
the prevention of cardiovascular disease or dementia. These drugs
have not yet come to market, but ERβ speciﬁc receptor agonists still
hold potential for treating certain cancers, as well as endometriosis, in-
ﬂammatory diseases including rheumatoid arthritis, cardiovascular and
CNS conditions (Minutolo et al., 2011). A novel phytoestrogen formula-
tion, referred to as the Phyto-β-SERM formulation, prolonged survival,
improved spatial recognition memory, and slowed progression of
amyloid pathology in a female mouse model of Alzheimer's disease
and is currently undergoing a trial in women where cognition will be
evaluated (Zhao et al., 2013). Finally, Bazedoxifene, a third generation
SERM, in combination with conjugated estrogens came to market in
January 2014 (www.Duavee.com) for preventing moderate to severe
hot ﬂashes and osteoporosis in post-menopausal women. Due to the
estrogen agonist/antagonist proﬁle of Bazedoxifene, this drug is expect-
ed to have fewer side effects than previous SERMS.
Another more recently described target for drug development is the
“Downstream Molecule” concept advanced by Frick (2012). In this
model, neuronal molecules and cellular mechanisms, which are down-
stream from hormone receptors and underlie the memory-enhancing
effects of estradiol, would be targeted (see the section Synthesis of
estradiol within brain areas). Such drugs would interact with cellular
signaling molecules rather than the receptors themselves and thus
shouldmimic the beneﬁcial, but not the deleterious, effects of estrogens
because they would be non-steroidal in nature. It is also possible that a
“cocktail” of estradiol and such drugs may be required in order to over-
come aging effects.
A ﬁnal approach for drug development is intra-neuronal modulation
of estrogen production and release. Increased availability of brain
derived estradiol should be beneﬁcial for cognitive functioning. Current-
ly drugs are available to inhibit aromatase and lower estradiol levels but
none activate aromatase. Allosteric activation of the enzyme itself or
increased synthesis of the enzyme protein could increase local estradiol
production and be beneﬁcial for cognition. Possible side effects of
increased aromatase are currently not known.
Conclusions
The ﬁeld of hormonal modulation of learning and memory has ad-
vanced enormously since Hormone and Behavior's landmark volume
on Estrogen Effects on Cognition across The Lifespan in 1998. However,
it is clear that the breadth and depth of new developments concerning
neural mechanisms for estradiol action as well as the dearth of new
HRTs indicate that researchers will continue to be engaged in this area
of neuroendocrine research in the near and far future.
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